• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天冬酰胺酶与氨基酸在癌症治疗中的应用。癌症与白血病B组研究人员。

Asparaginase and amino acids in cancer therapeutics. Cancer and Leukemia Group B Investigators.

作者信息

Holland J F, Ohnuma T

出版信息

Cancer Treat Rep. 1981;65 Suppl 4:123-30.

PMID:7049376
Abstract

Asparaginase was found ineffective in improving induction frequency of acute lymphocytic leukemia of children from vincristine and prednisone, but prolonged remission duration. Prolongation of remission duration was accomplished more effectively and at lower toxic cost by administration of asparaginase after the vincristine and prednisone treatment had been completed. Asparaginase is markedly more effective against human leukemia T-cells in vitro than against several types of B-lymphocytes. This is consistent with in vivo experience. Leukemic T-cells resistant to asparaginase have been induced in vitro. Deficiency of other amino acids causes absolute cessation of RNA biosynthesis, constituting evidence for other amino acid targets critical to leukemic cell survival.

摘要

天冬酰胺酶在提高长春新碱和强的松对儿童急性淋巴细胞白血病的诱导缓解率方面无效,但能延长缓解期。在长春新碱和强的松治疗完成后给予天冬酰胺酶,能更有效地延长缓解期,且毒性代价更低。天冬酰胺酶在体外对人白血病T细胞的作用明显比对几种B淋巴细胞类型的作用更有效。这与体内实验结果一致。已在体外诱导出对天冬酰胺酶耐药的白血病T细胞。其他氨基酸的缺乏会导致RNA生物合成完全停止,这为白血病细胞存活所必需的其他氨基酸靶点提供了证据。

相似文献

1
Asparaginase and amino acids in cancer therapeutics. Cancer and Leukemia Group B Investigators.天冬酰胺酶与氨基酸在癌症治疗中的应用。癌症与白血病B组研究人员。
Cancer Treat Rep. 1981;65 Suppl 4:123-30.
2
L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia.左旋门冬酰胺酶、长春新碱和泼尼松用于诱导急性淋巴细胞白血病首次缓解。
Cancer Res. 1977 Feb;37(2):535-40.
3
[Letter: Acute lymphoid leukemia: constant induction of remission by the combination of prednisone, vincristine and L-asparaginase (20 cases)].[信件:急性淋巴细胞白血病:泼尼松、长春新碱和L-天冬酰胺酶联合使用持续诱导缓解(20例)]
Nouv Presse Med. 1976 Jun 5;5(23):1491.
4
Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia Coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL).微小残留病(MRD)检测作为一种工具,用于比较在儿童急性淋巴细胞白血病(ALL)中使用大肠杆菌天冬酰胺酶或欧文氏菌天冬酰胺酶的化疗药物方案的疗效。
Pediatr Blood Cancer. 2006 Sep;47(3):299-304. doi: 10.1002/pbc.20684.
5
Effective dose of L-asparaginase for induction of remission in previously treated children with acute lymphocytic leukemia: a report from Childrens Cancer Study Group.
Cancer Res. 1979 Oct;39(10):3893-6.
6
L-Asparaginase as a single agent in acute lymphocytic leukemia: survey of studies form Childrens Cancer Study Group.
Cancer Treat Rep. 1981;65 Suppl 4:101-7.
7
Asparaginase in combination chemotherapy for remission induction of childhood acute lymphocytic leukemia.天冬酰胺酶联合化疗用于儿童急性淋巴细胞白血病缓解诱导治疗。
Cancer Res. 1973 Sep;33(9):2020-5.
8
Pharmacokinetics and drug monitoring of L-asparaginase treatment.L-天冬酰胺酶治疗的药代动力学与药物监测
Int J Clin Pharmacol Ther. 1997 Mar;35(3):96-8.
9
[Preliminary results of the clinical study of a Soviet--produced L-asparaginase from E. coli].[苏联产大肠杆菌L-天冬酰胺酶临床研究的初步结果]
Antibiotiki. 1977 Sep;22(9):852-7.
10
Erwinia carotovora asparaginase in patients with prior anaphylaxis to asparaginase from E. coli.患有先前对大肠杆菌天冬酰胺酶过敏的患者使用胡萝卜软腐欧文氏菌天冬酰胺酶。
Cancer. 1972 Aug;30(2):376-81. doi: 10.1002/1097-0142(197208)30:2<376::aid-cncr2820300212>3.0.co;2-4.

引用本文的文献

1
The effect of lysine deprivation on leukemic blood.赖氨酸缺乏对白血病血液的影响。
Amino Acids. 1992 Oct;3(3):213-21. doi: 10.1007/BF00805995.
2
Pharmacokinetic/pharmacodynamic relationships of asparaginase formulations: the past, the present and recommendations for the future.天冬酰胺酶制剂的药代动力学/药效学关系:过去、现在与未来建议
Clin Pharmacokinet. 2005;44(4):367-93. doi: 10.2165/00003088-200544040-00003.